These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 19330719

  • 1. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
    Panter G, Kuznik A, Jerala R.
    Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
    [Abstract] [Full Text] [Related]

  • 2. Nucleic acid recognition receptors in autoimmunity.
    Krug A.
    Handb Exp Pharmacol; 2008 Apr; (183):129-51. PubMed ID: 18071658
    [Abstract] [Full Text] [Related]

  • 3. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM, Vollmer J.
    Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
    [Abstract] [Full Text] [Related]

  • 4. Nucleic acid sensing Toll-like receptors in dendritic cells.
    Hoshino K, Kaisho T.
    Curr Opin Immunol; 2008 Aug; 20(4):408-13. PubMed ID: 18585458
    [Abstract] [Full Text] [Related]

  • 5. Nucleic acid recognizing Toll-like receptors and autoimmunity.
    von Landenberg P, Bauer S.
    Curr Opin Immunol; 2007 Dec; 19(6):606-10. PubMed ID: 18060756
    [Abstract] [Full Text] [Related]

  • 6. Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance.
    Ehlers M, Ravetch JV.
    Trends Immunol; 2007 Feb; 28(2):74-9. PubMed ID: 17197239
    [Abstract] [Full Text] [Related]

  • 7. Nucleic acid-sensing Toll-like receptors: beyond ligand search.
    Miyake K.
    Adv Drug Deliv Rev; 2008 Apr 29; 60(7):782-5. PubMed ID: 18321608
    [Abstract] [Full Text] [Related]

  • 8. Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.
    Goldman M.
    Clin Exp Immunol; 2007 Feb 29; 147(2):208-16. PubMed ID: 17223960
    [Abstract] [Full Text] [Related]

  • 9. Controlling systems of nucleic acid sensing-TLRs restrict homeostatic inflammation.
    Fukui R, Miyake K.
    Exp Cell Res; 2012 Aug 01; 318(13):1461-6. PubMed ID: 22507273
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic applications of nucleic acids and their analogues in Toll-like receptor signaling.
    Gosu V, Basith S, Kwon OP, Choi S.
    Molecules; 2012 Nov 14; 17(11):13503-29. PubMed ID: 23151919
    [Abstract] [Full Text] [Related]

  • 11. The role of toll-like receptors in chronic inflammation.
    Drexler SK, Foxwell BM.
    Int J Biochem Cell Biol; 2010 Apr 14; 42(4):506-18. PubMed ID: 19837184
    [Abstract] [Full Text] [Related]

  • 12. Recognition of nucleic acids by Toll-like receptors and development of immunomodulatory drugs.
    Kuznik A, Panter G, Jerala R.
    Curr Med Chem; 2010 Apr 14; 17(18):1899-914. PubMed ID: 20377514
    [Abstract] [Full Text] [Related]

  • 13. Insights into the role of Toll-like receptors in modulation of T cell responses.
    Kulkarni R, Behboudi S, Sharif S.
    Cell Tissue Res; 2011 Jan 14; 343(1):141-52. PubMed ID: 20680345
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic targeting of pattern-recognition receptors.
    Rezaei N.
    Int Immunopharmacol; 2006 Jun 14; 6(6):863-9. PubMed ID: 16644471
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic and therapeutic implications of toll-like receptor ligands.
    Hedayat M, Takeda K, Rezaei N.
    Med Res Rev; 2012 Mar 14; 32(2):294-325. PubMed ID: 22383179
    [Abstract] [Full Text] [Related]

  • 16. Toll-like receptors in autoimmunity.
    Fischer M, Ehlers M.
    Ann N Y Acad Sci; 2008 Nov 14; 1143():21-34. PubMed ID: 19076342
    [Abstract] [Full Text] [Related]

  • 17. Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development.
    Karikó K, Weissman D.
    Curr Opin Drug Discov Devel; 2007 Sep 14; 10(5):523-32. PubMed ID: 17786850
    [Abstract] [Full Text] [Related]

  • 18. The role of innate immunity in autoimmune tissue injury.
    Allam R, Anders HJ.
    Curr Opin Rheumatol; 2008 Sep 14; 20(5):538-44. PubMed ID: 18698174
    [Abstract] [Full Text] [Related]

  • 19. Toll-like receptors in inflammation of the central nervous system.
    Kong Y, Le Y.
    Int Immunopharmacol; 2011 Oct 14; 11(10):1407-14. PubMed ID: 21600311
    [Abstract] [Full Text] [Related]

  • 20. The significance of toll-like receptors in human diseases.
    Montero Vega MT, de Andrés Martín A.
    Allergol Immunopathol (Madr); 2009 Oct 14; 37(5):252-63. PubMed ID: 19853360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.